Turgeon RD, Barry AR, Pearson GJ. Familial hypercholesterolemia: review of diagnosis, screening, and treatment. Can Fam Physician. 2016;62(1):32–7.
PubMed PubMed Central Google Scholar
Chora JR, Medeiros AM, Alves AC, Bourbon M. Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: Application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis. Genet Med. 2018;20(6):591–8.
Article CAS PubMed Google Scholar
Sørensen S, Ranheim T, Bakken KS, Leren TP, Kulseth MA. Retention of mutant low density lipoprotein receptor in endoplasmic reticulum (ER) leads to ER stress. J Biol Chem. 2006;281(1):468–76.
Li Y, Lu W, Schwartz AL, Bu G. Degradation of the LDL receptor class 2 mutants is mediated by a proteasome-dependent pathway. J Lipid Res. 2004;45(6):1084–91. Available from: https://doi.org/10.1194/jlr.M300482-JLR200
Chen Y, Bellamy WP, Seabra MC, Field MC, Ali BR. ER-associated protein degradation is a common mechanism underpinning numerous monogenic diseases including Robinow syndrome. Hum Mol Genet. 2005;14(17):2559–69.
Article CAS PubMed Google Scholar
Tveten K, Holla ØL, Ranheim T, Berge KE, Leren TP, Kulseth MA. 4-Phenylbutyrate restores the functionality of a misfolded mutant low-density lipoprotein receptor. FEBS J. 2007;274(8):1881–93.
Article CAS PubMed Google Scholar
Kizhakkedath P, John A, Al-Gazali L, Ali BR. Degradation routes of trafficking-defective VLDLR mutants associated with Dysequilibrium syndrome. Sci Rep. 2018;8(1):1–12.
Gariballa N, Kizhakkedath P, Akawi N, John A, Ali BR. Endoglin wild type and variants associated with hereditary hemorrhagic telangiectasia type 1 undergo distinct cellular degradation pathways. Front Mol Biosci. 2022;9:828199. https://doi.org/10.3389/fmolb.2022.828199.
Mollazadeh H, Carbone F, Montecucco F, Pirro M, Sahebkar A. Oxidative burden in familial hypercholesterolemia. J Cell Physiol. 2018;233(8):5716–25.
Article CAS PubMed Google Scholar
Van Tits L, De Graaf J, Hak-Lemmers H, Bredie S, Demacker P, Holvoet P, et al. Increased levels of low-density lipoprotein oxidation in patients with familial hypercholesterolemia and in end-stage renal disease patients on hemodialysis. Lab Investig. 2003;83(1):13–21.
Gao S, Zhao D, Wang M, Zhao F, Han X, Qi Y, et al. Association Between Circulating Oxidized LDL and Atherosclerotic Cardiovascular Disease: A Meta-analysis of Observational Studies. Can J Cardiol. 2017;33(12):1624–32.
Yang L, Sun J, Li M, Long Y, Zhang D, Guo H, Huang RYJ. Oxidized Low-Density Lipoprotein Links Hypercholesterolemia and Bladder Cancer Aggressiveness by Promoting Cancer Stemness. Cancer Res. 2021;81(22):5720–32.
Article CAS PubMed Google Scholar
Burchill MA, Finlon JM, Goldberg AR, Gillen AE, Dahms PA, McMahan RH, et al. Oxidized Low-Density Lipoprotein Drives Dysfunction of the Liver Lymphatic System. Cmgh . 2021;11(2):573–95. Available from: https://doi.org/10.1016/j.jcmgh.2020.09.007
Sanson M, Augé N, Vindis C, Muller C, Bando Y, Thiers JC, et al. Oxidized low-density lipoproteins trigger endoplasmic reticulum stress in vascular cells: Prevention by oxygen-regulated protein 150 expression. Circ Res. 2009;104(3):328–36.
Article CAS PubMed Google Scholar
Yin X-M. Autophagy in Liver Diseases: A Matter of What to Remove and Whether to Keep. Liver Res. 2018;2(3):109–11.
Article PubMed PubMed Central Google Scholar
Mariño G, Niso-Santano M, Baehrecke EH, Kroemer G. Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol. 2014;15(2):81–94. https://doi.org/10.1038/nrm3735.
Article CAS PubMed PubMed Central Google Scholar
Ramachandran A, Lebofsky M, Baines CP, Lemasters JJ, Jaeschke H. Cyclophilin D deficiency protects against acetaminophen-induced oxidant stress and liver injury. Free Radic Res. 2011;45(2):156–64. https://doi.org/10.3109/10715762.2010.520319.
Article CAS PubMed Google Scholar
Wang X, Du H, Shao S, Bo T, Yu C, Chen W, et al. Cyclophilin D deficiency attenuates mitochondrial perturbation and ameliorates hepatic steatosis. Hepatology. 2018;68(1):62–77. https://doi.org/10.1002/hep.29788.
Article CAS PubMed Google Scholar
Newton K, Manning G. Necroptosis and Inflammation. Annu Rev Biochem. 2016;85:743–63.
Article CAS PubMed Google Scholar
Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang JG, Alvarez-Diaz S, Lewis R, Lalaoui N, Metcalf D, Webb AI, et al. The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism. Immunity. 2013;39:443–52.
Article CAS PubMed Google Scholar
Degterev A, Hitomi J, Germscheid M, Ch’en IL, Korkina O, Teng X, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008;4(5):313–21. https://doi.org/10.1038/nchembio.83.
Article CAS PubMed PubMed Central Google Scholar
Dara L, Liu ZX, Kaplowitz N. Questions and controversies: the role of necroptosis in liver disease. Cell Death Discov . 2016;2(1):1–10. Available from: https://doi.org/10.1038/cddiscovery.2016.89
Li X, Wang TX, Huang X, Li Y, Sun T, Zang S, et al. Targeting ferroptosis alleviates methionine-choline deficient (MCD)-diet induced NASH by suppressing liver lipotoxicity. Liver Int. 2020;40(6):1378–94.
Article CAS PubMed Google Scholar
Tsurusaki S, Tsuchiya Y, Koumura T, Nakasone M, Sakamoto T, Matsuoka M, et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. Cell Death Dis. 2019;10(6). Available from: https://doi.org/10.1038/s41419-019-1678-y
Gautheron J, Gores GJ. RCMP. Lytic cell death in metabolic liver disease. J Hepatol. 2020;73(2):394–408.
Article CAS PubMed PubMed Central Google Scholar
Xu B, Jiang M, Chu Y, Wang W, Chen D, Li X, Zhang Z, Zhang D, Fan D, Nie Y, et al. Gasdermin D Plays a Key Role as a Pyroptosis Executor of Non-Alcoholic Steatohepatitis in Humans and Mice. J Hepatol. 2018;68:773–82.
Article CAS PubMed Google Scholar
Liu Z, Wang M, Wang X, Bu Q, Wang Q, Su W, et al. XBP1 deficiency promotes hepatocyte pyroptosis by impairing mitophagy to activate mtDNA-cGAS-STING signaling in macrophages during acute liver injury. Redox Biol. 2022;52:102305. Available from: https://doi.org/10.1016/j.redox.2022.102305
Nass KJ, van den Berg EH, Faber KN, Schreuder TCMA, Blokzijl H, Dullaart RPF. High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study. Metabolism. 2017;72:37–46.
Article CAS PubMed Google Scholar
van den Berg EH, Wolters AAB, Dullaart RPF, Moshage H, Zurakowski D, de Meijer VEBH. Prescription of statins in suspected non-alcoholic fatty liver disease and high cardiovascular risk, a population-based study. Liver Int. 2019;39(7):1343–54.
Article PubMed PubMed Central Google Scholar
Bril F, Sninsky JJ, Baca AM, Superko HR, Sanchez PP, Biernacki Di, et al. Hepatic steatosis and insulin resistance, but not steatohepatitis, promote atherogenic dyslipidemia in NAFLD. J Clin Endocrinol Metab. 2016;101(2):644–52.
Article CAS PubMed Google Scholar
Kizhakkedath P, et al. Endoplasmic reticulum quality control of LDLR variants associated with familial hypercholesterolemia. FEBS Open Bio. 2019;9(11):1994–2005.
Article CAS PubMed PubMed Central Google Scholar
Ye J, Rawson RB, Komuro R, Chen X, Davé UP, Prywes R, et al. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell. 2000;6(6):1355–64.
Article CAS PubMed Google Scholar
Chen X, Shen J, Prywes R. The luminal domain of ATF6 senses endoplasmic reticulum (ER) stress and causes translocation of ATF6 from the er to the Golgi. J Biol Chem . 2002;277(15):13045–52. Available from: https://doi.org/10.1074/jbc.M110636200
Hillary RF, FitzGerald U. A lifetime of stress: ATF6 in development and homeostasis. J Biomed Sci. 2018;25(1):48. https://doi.org/10.1186/s12929-018-0453-1.
Article CAS PubMed PubMed Central Google Scholar
Haze K, Yoshida H, Yanagi H, Yura T, Mori K. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell. 1999;10(11):3787–99.
Article CAS PubMed PubMed Central Google Scholar
Yu S, Wong SL, Lau CW, Huang Y, Yu CM. Oxidized LDL at low concentration promotes in-vitro angiogenesis and activates nitric oxide synthase through PI3K/Akt/eNOS pathway in human coronary artery endothelial cells. Biochem Biophys Res Commun. 2011;407(1):44–8.
Article CAS PubMed Google Scholar
Yan G, Jiang S, Yu L, Liu S. Oxidized low density lipoprotein (oxLDL) promotes mitochondrial dysfunction and induces apoptosis in retinal pigmented epithelium cells. Int J Clin Exp Pathol. 2017;10(2):1619–26.
Takayanagi S, Fukuda R, Takeuchi Y, Tsukada S, Yoshida K. Gene regulatory network of unfolded protein response genes in endoplasmic reticulum stress. Cell Stress Chaperones. 2013;18(1):11–23.
Article CAS PubMed Google Scholar
Di Pietro N, Formoso G, Pandolfi A. Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis. Vascul Pharmacol. 2016;84:1–7.
Frostegård J. Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013;11(1):1–8.
Tian Y, Wong VWS, Chan HLY, Cheng ASL. Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease. Semin Cancer Biol. 2013;23(6 PB):471–82.
留言 (0)